JEREMY LEVIN - CEO, Director at Ovid Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Issuer Symbol
OVID on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by JEREMY LEVIN since 05 Jan 2025

Holdings reported by JEREMY LEVIN for Ovid Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3,687,715 $5,531,572 $1.50 15 Dec 2025 Direct
Common Stock 35,461 $53,191 $1.50 11 Dec 2025 Indirect
Employee Stock Option (Right to Buy) 1,650,000 20 Feb 2025 Direct Common Stock
Series A Warrant (right to buy) 47,333 11 Dec 2025 Direct Common Stock
Series B Warrant (right to buy) 35,500 11 Dec 2025 Direct Common Stock
Series B Convertible Preferred Stock 0 15 Dec 2025 Direct Common Stock

Transactions reported by JEREMY LEVIN for Ovid Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.